JPS6098988A - Ｌｐｆ−ｈａの精製法 - Google Patents

Ｌｐｆ−ｈａの精製法

Info

Publication number
JPS6098988A
JPS6098988A JP58206598A JP20659883A JPS6098988A JP S6098988 A JPS6098988 A JP S6098988A JP 58206598 A JP58206598 A JP 58206598A JP 20659883 A JP20659883 A JP 20659883A JP S6098988 A JPS6098988 A JP S6098988A
Authority
JP
Japan
Prior art keywords
ceruloplasmin
lpf
ligand
modified
item
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58206598A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6262153B2 (enExample
Inventor
Susumu Sakuma
晋 作間
Kuniaki Sakamoto
坂本　国昭
Hisashi Kitagawa
北川　久
Mitsuo Sako
酒匂　光郎
Jitsuo Nonaka
野中　実男
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemo Sero Therapeutic Research Institute Kaketsuken
Original Assignee
Chemo Sero Therapeutic Research Institute Kaketsuken
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeutic Research Institute Kaketsuken filed Critical Chemo Sero Therapeutic Research Institute Kaketsuken
Priority to JP58206598A priority Critical patent/JPS6098988A/ja
Priority to US06/666,172 priority patent/US4704274A/en
Priority to DE8484113134T priority patent/DE3483344D1/de
Priority to EP84113134A priority patent/EP0140386B1/en
Priority to CA000466753A priority patent/CA1210720A/en
Publication of JPS6098988A publication Critical patent/JPS6098988A/ja
Publication of JPS6262153B2 publication Critical patent/JPS6262153B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP58206598A 1983-11-01 1983-11-01 Ｌｐｆ−ｈａの精製法 Granted JPS6098988A (ja)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP58206598A JPS6098988A (ja) 1983-11-01 1983-11-01 Ｌｐｆ−ｈａの精製法
US06/666,172 US4704274A (en) 1983-11-01 1984-10-26 Method for the purification of LPF-HA
DE8484113134T DE3483344D1 (de) 1983-11-01 1984-10-31 Verfahren zur reinigung von lpf-ha.
EP84113134A EP0140386B1 (en) 1983-11-01 1984-10-31 Method for the purification of lpf-ha
CA000466753A CA1210720A (en) 1983-11-01 1984-10-31 Method for the purification of leucocytosis-promoting factor hemagglutinin (lpf-ha)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58206598A JPS6098988A (ja) 1983-11-01 1983-11-01 Ｌｐｆ−ｈａの精製法

Publications (2)

Publication Number Publication Date
JPS6098988A true JPS6098988A (ja) 1985-06-01
JPS6262153B2 JPS6262153B2 (enExample) 1987-12-24

Family

ID=16526042

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58206598A Granted JPS6098988A (ja) 1983-11-01 1983-11-01 Ｌｐｆ−ｈａの精製法

Country Status (5)

Country Link
US (1) US4704274A (enExample)
EP (1) EP0140386B1 (enExample)
JP (1) JPS6098988A (enExample)
CA (1) CA1210720A (enExample)
DE (1) DE3483344D1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62258326A (ja) * 1986-04-16 1987-11-10 パスツール　メリウー　セロム　エ　ヴアクサン ボルデテラ属細菌の蛋白質抗原の精製方法

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6176422A (ja) * 1984-09-22 1986-04-18 Chemo Sero Therapeut Res Inst 百日ぜきコンポ−ネントワクチンおよび百日ぜき・ジフテリア・破傷風混合ワクチンの製造方法
KR890001003B1 (ko) * 1984-07-19 1989-04-18 자이단 호오진 까가꾸 오요비 겟세이 료오호 겐뀨쇼 Lpf-ha의 정제방법
GB8601279D0 (en) * 1986-01-20 1986-02-26 Public Health Lab Service Purification of pertussis antigens
CA1340373C (en) * 1986-01-28 1999-02-02 Rino Rappuoli Cloning and sequencing of the dna fragment which codes for the five subunits of the pertussis toxin, a hybrid plasmid containing the dna fragment and micro-organisms transformed by the hybrid plasmid and capable of expressing all or some of the subunits of the pertussis toxin
FR2597605B1 (fr) * 1986-04-16 1989-06-23 Merieux Inst Nouveau materiau pour chromatographie d'affinite et son application a la separation et a la purification des antigenes proteiques des bacteries du genre bordetella
JPH0789951B2 (ja) * 1986-06-18 1995-10-04 財団法人阪大微生物病研究会 遺伝子発現産物の精製法
US4791192A (en) * 1986-06-26 1988-12-13 Takeda Chemical Industries, Ltd. Chemically modified protein with polyethyleneglycol
US5139776A (en) * 1987-04-24 1992-08-18 The Research Foundation For Microbial Diseases Of Osaka University Method for culturing Bordetella pertussis, a pertussis toxoid and a pertussis vaccine
CA1337859C (en) * 1987-04-24 1996-01-02 Masashi Chazono Method for culturing bordetella pertussis, a pertussis toxoid and a pertussis vaccine
US5626851A (en) * 1987-11-30 1997-05-06 The Wistar Institute Of Anatomy And Biology Rotavirus reassortant vaccine
US5277818A (en) * 1988-10-31 1994-01-11 The Green Cross Corporation Albumin preparation and process for preparing the same
DE69025375T2 (de) 1989-11-06 1996-08-01 Smithkline Beecham Biolog Verfahren
US5391715A (en) * 1989-11-06 1995-02-21 Smithkline Beecham Biologicals Method for isolating and purifying bordetella pertussis antigenic factors
FR2672895B1 (fr) * 1991-02-15 1995-05-12 Transgene Sa Procede de purification d'une proteine fortement glycosylee.
US5595732A (en) * 1991-03-25 1997-01-21 Hoffmann-La Roche Inc. Polyethylene-protein conjugates
HU214452B (hu) * 1992-06-01 1998-03-30 BIOGAL Gyógyszergyár Rt. Eljárás nagytisztaságú deferoxamin-B-sók előállítására
US5382657A (en) * 1992-08-26 1995-01-17 Hoffmann-La Roche Inc. Peg-interferon conjugates
US5317040A (en) * 1993-01-26 1994-05-31 Washington University Method for the treatment of pertussis with aminoguanidine
US9481881B2 (en) * 2011-01-12 2016-11-01 Sekisui Medical Co., Ltd. Eluent for ion-exchange chromatography, and method of analyzing nucleic acid chains
JP6061381B2 (ja) 2011-01-12 2017-01-18 積水メディカル株式会社 一塩基多型の検出方法
US9534029B2 (en) 2012-10-03 2017-01-03 Csl Behring Ag Method of purifying proteins

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4247452A (en) * 1978-03-01 1981-01-27 The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Purification of pertussis haemagglutinins
DE3176491D1 (en) * 1980-03-05 1987-11-26 Miles Lab Pasteurized therapeutically active protein compositions
JPS572688A (en) * 1980-06-09 1982-01-08 Ajinomoto Co Inc Preparation of l-threonine by fermentation method
US4551429A (en) * 1983-09-15 1985-11-05 American Home Products Corporation Stimulation of antigen production by Bordetella pertussis
AU571078B2 (en) * 1984-04-14 1988-03-31 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Purification of filamentous hemagglutinin

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62258326A (ja) * 1986-04-16 1987-11-10 パスツール　メリウー　セロム　エ　ヴアクサン ボルデテラ属細菌の蛋白質抗原の精製方法

Also Published As

Publication number Publication date
CA1210720A (en) 1986-09-02
EP0140386A3 (en) 1987-03-04
JPS6262153B2 (enExample) 1987-12-24
DE3483344D1 (de) 1990-11-08
EP0140386A2 (en) 1985-05-08
EP0140386B1 (en) 1990-10-03
US4704274A (en) 1987-11-03

Similar Documents

Publication Publication Date Title
JPS6098988A (ja) Ｌｐｆ−ｈａの精製法
JPH01311028A (ja) 肝炎蛋白質の精製
JP3554796B2 (ja) アルブミン製剤及びその製造方法
US20100055134A1 (en) Method of separating protective components of bordetella pertussis
JPS63502427A (ja) ナイセリア・ゴノロエアエの主要鉄調整タンパクおよびワクチンとしてのその用途
JPS63503352A (ja) タンパク質の精製
JPH04295432A (ja) 血液凝固ｉｘ因子を含有する複合体
EP0175841B1 (en) Method for the production of pertussis component vaccine and combined vaccine of pertussis antigen; diphtheria toxoid and tetanus toxoid
JPH051280B2 (enExample)
JPS62258326A (ja) ボルデテラ属細菌の蛋白質抗原の精製方法
JPH03169893A (ja) 精製方法
RU2769201C2 (ru) Способ получения высокоочищенного рекомбинантного ингибитора с1-эстеразы человека для медицинского применения
JP3476242B2 (ja) インフルエンザｈａ蛋白の精製方法
JPS58404B2 (ja) ステロイド結合性グロブリンの製造方法
JPS61103895A (ja) ＨＢｓＡｇの精製方法
JP3747077B2 (ja) 百日咳菌由来感染防御成分の分離取得方法
JPH05170799A (ja) ヒトインターロイキン８の精製方法
JP2721961B2 (ja) 血液製剤
JPS6241692B2 (enExample)
JPS6030292B2 (ja) 人顆粒球の分化増殖を促進する加熱処理ｈｇｉｇｐ及びｈｇｉｇｐの加熱処理法
JPH04506075A (ja) インターフェロン精製方法
JP4706093B2 (ja) パルボウイルスの除去方法及び精製方法
JPS6087300A (ja) インタ−フエロン−γ組成物
JPH01258700A (ja) 血液凝固第４因子の精製方法
JPS641447B2 (enExample)